Case Study: a Fortune 500 pharmaceutical company achieves $40M+ in identified corrective actions with PRGX Contract Management

Fortune 500 Pharmaceutical Company - Customer Case Study

A Fortune 500 pharmaceutical company was challenged by unwieldy payments and expenses related to its global clinical trials, which had an auditable spend of $800 million. The company faced a lack of visibility and control, leading to overcharges, foreign exchange errors, and excessive travel expenses. To address this, the company engaged PRGX and its AI-powered Contract Management services.

review. This process identified over $40 million in future savings and realized $13 million in cash recoveries by correcting inaccurate payments and insufficient controls. The solution provided the client with greater financial oversight and helped prevent future leakage.